Belzutifan 40mg Tablet – Imported | Lucius Pharmaceuticals

Product Overview

Belzutifan 40mg Tablet – Imported is an oral targeted anticancer medicine containing belzutifan, a hypoxia-inducible factor 2 alpha (HIF-2α) inhibitor. It works by blocking a protein involved in tumor growth and the body’s response to low oxygen levels. Belzutifan is used for specific cancers and tumors under specialist medical supervision, depending on the patient’s diagnosis and treatment history.

Belzutifan is an established treatment option for selected patients with von Hippel-Lindau (VHL) disease-associated tumors, advanced renal cell carcinoma (RCC), and certain pheochromocytomas or paragangliomas. Its suitability depends on the approved indication and the individual treatment plan.

The Belzutifan 40mg Tablet, listed with Lucius Pharmaceuticals, is intended for patients whose oncologist has prescribed this medicine. The listed pack size is 90 tablets. Patients and caregivers should confirm the product’s authenticity, packaging, and availability before purchase.

Key Product Information

• Product Name: Belzutifan 40mg Tablet
• Active Ingredient: Belzutifan
• Strength: 40mg
• Dosage Form: Tablet
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 90 Tablets
• Product Type: Imported medicine
• Therapeutic Category: Targeted anticancer therapy
• Drug Class: HIF-2α inhibitor
• Primary Use: Treatment of certain cancers and tumors as prescribed by a specialist
• Availability in Pakistan: Contact MedicineWalyDost.com to confirm current stock, price, and delivery arrangements.

What Is Belzutifan 40mg Used For?

Belzutifan is prescribed for specific conditions in which HIF-2α signaling contributes to tumor development or progression.

1. Von Hippel-Lindau (VHL) Disease

Belzutifan may be prescribed to eligible adults with VHL disease who require treatment for associated renal cell carcinoma, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors when immediate surgery is not required.

2. Advanced Renal Cell Carcinoma

Belzutifan is used in certain patients with advanced clear-cell renal cell carcinoma, including those whose disease has progressed after specified previous treatments. Depending on the clinical setting, it may also be used in an approved combination regimen following surgery to reduce the risk of recurrence.

3. Pheochromocytoma and Paraganglioma

Belzutifan is also approved for eligible adults and children aged 12 years and older with locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma.

The precise indication depends on the patient’s age, diagnosis, prior treatment, and the locally applicable prescribing information.

How Does Belzutifan Work?

Belzutifan targets hypoxia-inducible factor 2 alpha (HIF-2α), a protein involved in cellular responses to oxygen availability and the regulation of genes associated with tumor growth.

In certain tumors, abnormal HIF-2α signaling supports cancer-cell survival and progression. Belzutifan inhibits this pathway, helping interfere with the biological processes that support tumor growth.

Because it targets a specific pathway, belzutifan differs from conventional chemotherapy. However, it can still cause serious side effects and requires regular monitoring by a qualified healthcare professional.

Dosage and Administration

Belzutifan 40mg Tablets must be taken exactly as directed by the prescribing specialist.

• The appropriate dose depends on the specific indication, age, body weight where applicable, other treatments, and individual tolerance.
• The 40mg tablet strength may be used to achieve a prescribed total daily dose.
• Take the medicine by mouth according to the prescribed schedule. Belzutifan is generally administered once daily and may be taken with or without food, according to the applicable product instructions.
• Swallow tablets according to the directions supplied with the product.
• If a dose is missed or vomiting occurs after taking a dose, follow the patient leaflet or contact the treating healthcare professional for instructions.
• Do not take extra tablets to compensate for a missed dose.
• Never adjust the dose or discontinue treatment without consulting the prescribing specialist.

Important: The 40mg strength does not necessarily represent the complete daily dose. The recommended regimen varies by indication and patient circumstances. Follow the exact prescription and official product information.

Possible Side Effects of Belzutifan

Belzutifan may cause side effects that vary according to the patient and treatment regimen.

Common or clinically important adverse effects include:

• Anemia or decreased hemoglobin levels
• Fatigue and weakness
• Dizziness
• Headache
• Nausea
• Musculoskeletal pain
• Changes in kidney-related laboratory results
• Changes in liver enzymes
• Decreased appetite
• Electrolyte abnormalities

Your healthcare professional may recommend blood tests and other assessments during treatment to detect adverse effects early.

Serious Side Effects and Warnings

Anemia: Belzutifan can lower hemoglobin levels and reduce the blood’s ability to carry oxygen. Severe anemia may require treatment interruption, dose adjustment, or additional medical care.

Hypoxia: The medicine can reduce oxygen levels in the blood. New or worsening shortness of breath, unusual confusion, bluish lips, or severe breathing difficulty requires urgent medical assessment.

Pregnancy-related risks: Belzutifan can harm an unborn baby. Pregnancy status and appropriate contraception should be discussed before treatment begins.

Seek medical advice promptly if you experience significant weakness, breathing difficulties, fainting, or other severe or unexpected symptoms.

Precautions and Warnings

Before taking Belzutifan 40mg Tablets, inform your doctor about your medical history and all medicines you currently use.

Blood Count Monitoring

Regular blood tests may be needed to monitor hemoglobin and identify anemia. Your doctor may modify treatment based on the severity of laboratory abnormalities and your symptoms.

Oxygen Levels

Your healthcare professional may assess oxygen saturation before and during treatment. Report breathing difficulties or unusual reductions in exercise tolerance promptly.

Pregnancy and Contraception

Belzutifan may cause fetal harm. Patients who could become pregnant should discuss pregnancy testing and effective contraception with their healthcare professional. Belzutifan may reduce the effectiveness of certain hormonal contraceptives, so additional or non-hormonal contraception may be necessary.

Patients who could father a child should also discuss appropriate precautions with their healthcare professional.

Breastfeeding

Discuss breastfeeding with your doctor before starting treatment and follow the applicable product-specific guidance on whether and when breastfeeding may be resumed.

Existing Medical Conditions

Tell your doctor about anemia, low oxygen levels, kidney or liver problems, pregnancy, or any other significant medical condition.

Drug Interactions

Belzutifan can interact with other medicines and may affect the effectiveness of certain treatments, including some hormonal contraceptives. It can also influence how the body processes specific medicines.

Before starting treatment, provide your doctor or pharmacist with a complete list of:

• Prescription medicines
• Non-prescription medicines
• Vitamins and nutritional supplements
• Herbal products
• Hormonal contraceptives
• Other cancer treatments

Do not start, stop, or change any medicine without professional advice.

Who Should Use Belzutifan 40mg Tablets?

Belzutifan may be appropriate for patients with specific cancers or tumor conditions that meet the relevant treatment criteria. A qualified oncologist or specialist must determine whether the medicine is suitable.

It is not intended for self-treatment or for use without a confirmed diagnosis and appropriate prescription. The decision to use belzutifan should consider previous treatments, the type and stage of disease, laboratory results, and potential risks.

Storage Instructions

• Store the medicine according to the manufacturer’s instructions on the packaging.
• Protect the tablets from unsuitable temperatures and moisture.
• Keep the medicine in its original packaging where appropriate.
• Keep out of the reach of children.
• Do not use tablets beyond the expiry date.
• Do not use damaged or suspicious packaging.
• Ask a pharmacist about the safe disposal of unused medicine.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com helps customers explore information about imported medicines and enquire about product availability.

• Product information: Learn about the active ingredient, strength, and general therapeutic use.
• Imported medicine enquiries: Ask about Belzutifan 40mg Tablet availability.
• Pack-size details: The listed pack size is 90 tablets; verify the supplied packaging before purchase.
• Price enquiries: Contact the team for the latest price and stock information.
• Prescription guidance: Confirm the prescription and specialist requirements before ordering.

For medicines used in cancer treatment, always verify the product’s authenticity, manufacturer details, packaging, and regulatory status with a qualified pharmacist or healthcare professional.

Frequently Asked Questions (FAQs)

1. What is Belzutifan 40mg Tablet used for?

Belzutifan is a targeted medicine used for certain VHL-associated tumors, advanced renal cell carcinoma, and eligible cases of pheochromocytoma or paraganglioma. The indication depends on the patient’s clinical circumstances.

2. Who is the manufacturer of Belzutifan 40mg Tablet listed here?

The manufacturer is listed as Lucius Pharmaceuticals. Confirm the manufacturer’s details on the actual product packaging before use.

3. What is the pack size of Belzutifan 40mg Tablet?

The listed pack size is 90 tablets. Confirm the pack configuration with the supplier before purchase.

4. Is Belzutifan a chemotherapy medicine?

Belzutifan is a targeted anticancer medicine known as a HIF-2α inhibitor. Although it works differently from conventional chemotherapy, it can still cause serious adverse effects.

5. How should Belzutifan 40mg be taken?

Take it according to the exact prescription issued by your specialist. The 40mg strength may form part of a larger prescribed daily dose, so do not determine your dose from tablet strength alone.

6. What are the important side effects of Belzutifan?

Important risks include anemia and low blood oxygen levels. Regular monitoring is essential, and new or worsening breathing difficulties require prompt medical attention.

7. Can Belzutifan be used during pregnancy?

Belzutifan can harm an unborn baby. Discuss pregnancy testing and effective contraception with your healthcare professional before and during treatment as directed.

8. How can I check the price in Pakistan?

Contact MedicineWalyDost.com to confirm the current price, availability, prescription requirements, and delivery arrangements.

Conclusion

Belzutifan 40mg Tablet – Imported is a targeted anticancer medicine used for selected tumor conditions under specialist supervision. It works by inhibiting HIF-2α and requires careful monitoring for anemia, low oxygen levels, and other potential adverse effects.

The product is listed as manufactured by Lucius Pharmaceuticals, with a pack size of 90 tablets. Contact MedicineWalyDost.com to confirm availability, current pricing, packaging details, and prescription requirements before purchase.